The pathogenesis of heart failure is determined by the ventricular and
vascular responses to myocellular injury. Experimental and clinical s
tudies suggest that the vascular endothelium may play an important rol
e in modulating progression of ventricular and vascular remodeling in
heart failure. Endothelial cell dysfunction has been described in the
coronary and skeletal muscle circulations of patients with heart failu
re and appears to be characterized by decreased endothelial synthesis
of nitric oxide and increased production of endothelin-l. The pathogen
esis of endothelial dysfunction in hear? failure is unknown, but may b
e related to increased oxidative stress, abnormal regional flow condit
ions, and cytokine and neurohormonal activation. The specific role of
endothelial dysfunction in the pathogenesis of heart failure remains t
o be determined. If endothelial dysfunction does contribute to progres
sion of disease in early heart failure, specific therapies to enhance
endothelial dysfunction may improve long-term morbidity and mortality.